Ignite Creation Date:
2024-05-06 @ 1:10 PM
Last Modification Date:
2024-10-26 @ 1:10 PM
Study NCT ID:
NCT03959150
Status:
UNKNOWN
Last Update Posted:
2021-04-30
First Post:
2019-05-18
Brief Title:
Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Organization Data
Organization:
Ruijin Hospital
Class:
OTHER
Study ID:
Metro-PC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ruijin Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Jun Zhang
Responsible Party Title:
Chair of Department of Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Ruijin Hospital
Old Name:
None
Old Organization:
None